Form 4: Leap Therapeutics Executive Reports Stock Transaction

Sentiment:

Insider Transaction (Form 4)


William Patrick Mcevoy Iii, Chief Investment Officer, a Director and 10% owner of Leap Therapeutics, Inc., reported multiple transactions in common stock on August 17, 2026.

Summary

  • In-the-money derivative exercise: acquired 16,570,852 Common Stock at $0.00 ($16,571) on August 17, 2026; holds 24,854,613 after (Indirect).
  • In-the-money derivative exercise: disposed of 16,570,852 Pre-Funded Warrant (Right to Buy) at $0.52 ($8,610,215) on August 17, 2026; holds 58,877,766 after (Indirect).
  • Other acquisition/disposition: acquired 43,290,042 Pre-Funded Warrant (Right to Buy) at $0.77 ($33,333,332) on August 17, 2026; holds 102,167,808 after (Indirect).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

William Patrick Mcevoy Iii — Director, Officer (Chief Investment Officer), 10% owner

DateTransactionSecuritySharesPriceValueHeld After
2026-08-17In-the-money derivative exerciseCommon Stock16,570,852$0$16.6K24,854,613
2026-08-17In-the-money derivative exercisePre-Funded Warrant (Right to Buy)16,570,852$1$8.6M58,877,766
2026-08-17Other acquisition/dispositionPre-Funded Warrant (Right to Buy)43,290,042$1$33.3M102,167,808

Key Dates

DateDescription
2026-08-17In-the-money derivative exercise (16,570,852 shares)
2026-08-17In-the-money derivative exercise (16,570,852 shares)
2026-08-17Other acquisition/disposition (43,290,042 shares)

Keywords

insider transaction, Form 4, CYPH, CYPHERPUNK TECHNOLOGIES INC., neutral, William Patrick Mcevoy Iii

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.